International Journal of Biological Sciences

Impact factor
3.873

ISSN 1449-2288

News feeds of IJBS published articles
My Manuscript
My Account

Journal of Biomedicinenew

Theranostics

International Journal of Medical Sciences

Journal of Cancer

Oncomedicine

Journal of Genomics

Journal of Bone and Joint Infection (JBJI)

Nanotheranostics

PubMed Central Indexed in Journal Impact Factor

Int J Biol Sci 2014; 10(4):396-403. doi:10.7150/ijbs.8193

Research Paper

SRC-1 and Twist1 Expression Positively Correlates with a Poor Prognosis in Human Breast Cancer

Yan Xu1, Baoquan Hu1, Li Qin2, Lianhua Zhao3, Qiang Wang4, Qingliang Wang4, Yixiang Xu2, Jun Jiang1✉

1. Breast Disease Center, Southwest Hospital, Third Military Medical University, Chongqing, China.
2. Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas.
3. Department of Pathology, Daping Hospital, Third Military Medical University, Chongqing, China.
4. Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University, Chongqing, China.

Abstract

To evaluate the possible prognostic value of Steroid Receptor Coactivator-1 (SRC-1) and Twist1 expression in human breast cancer, we examined SRC-1 and Twist1 expression using immunohistochemistry on tissue microarray sections containing 137 breast cancer specimens. All patients were followed up for a median of 5 years following surgery. Survival curves were generated using the Kaplan-Meier method. Multivariate analysis was performed using the Cox proportional hazard regression model to assess the prognostic values. The results showed a positive correlation between SRC-1 and Twist1 expression at protein levels (P < 0.001). Also, SRC-1 expression positively correlated with HER2 expression (P = 0.024). The protein expression of Twist1 positively associated with lymph node metastasis (P < 0.001), but inversely correlated with PR status (P = 0.041). Patients with SRC-1 or Twist1-positive expression exhibited poorer overall survival (OS) and disease-free survival (DFS) than did those with SRC-1 or Twist1-negative expression (P < 0.05 for all). In addition, SRC-1-negativeive/Twist1-negative patients had the best OS and DFS (P < 0.01 for both). In multivariate survival analysis, SRC-1 expression, tumor stage, and PR were found to be independent prognostic factors related to OS (P = 0.019, < 0.001 and 0.02, respectively) and Twist1 expression, lymph node status and PR were independent predictors of DFS (P = 0.006, 0.001 and 0.029, respectively). These results suggest that a combined SRC-1/Twist1 expression status could improve the prognostic judgment for breast cancer patients.

Keywords: SRC-1, Twist1, Correlation, Breast cancer, Prognosis.

This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) License. See http://ivyspring.com/terms for full terms and conditions.
How to cite this article:
Xu Y, Hu B, Qin L, Zhao L, Wang Q, Wang Q, Xu Y, Jiang J. SRC-1 and Twist1 Expression Positively Correlates with a Poor Prognosis in Human Breast Cancer. Int J Biol Sci 2014; 10(4):396-403. doi:10.7150/ijbs.8193. Available from http://www.ijbs.com/v10p0396.htm